Jenny Lane Discusses The Journey Of Hydroxychloroquine

Jenny Lane co-led the OHDSI global network study on the safety profile of hydroxychloroquine, which was just published by Lancet Rheumatology. She joined the first OHDSI podcast to discuss the study findings, the journey of hydroxychloroquine throughout COVID, her own personal connection to the study, the clinical and methodological impacts of the study while in preprint, and how the OHDSI tenets of collaboration and open science drove this research.

#JoinTheJourney